Graft function and dysfunction after transplantation
How kidney, liver and lung transplant studies measure early graft function using dialysis, laboratory tests and lung injury grades.
How do studies measure graft function?
Graft function describes how well a transplanted organ performs its work in the recipient. A study may measure function through a laboratory result, a treatment the recipient needed or a clinical grading system. To read the result, start with the organ, the measurement and the time window.
Delayed graft function (DGF), early allograft dysfunction (EAD) and primary graft dysfunction (PGD) are terms used for different outcomes. Each depends on a definition. The examples below show how those definitions work in kidney, liver and lung studies.
Kidney: dialysis and the creatinine trajectory
Hall and colleagues followed 560 recipients of kidneys from deceased donors. They compared a first-week dialysis definition with a definition that included impaired creatinine reduction in the first 48 hours or more than one dialysis session. The first definition classified 215 recipients as having DGF. The combined definition classified 330.
Each definition was associated with lower adjusted estimated glomerular filtration rate at 12 months. Changing the definition changed how many people were classified. A useful kidney study reports its dialysis criterion, the creatinine trajectory and the later assessment of filtration separately.
Liver: markers of injury and function
Olthoff and colleagues tested an EAD definition in 300 deceased-donor liver transplants across three US programmes. It combined day-seven bilirubin and international normalized ratio (INR) with an aminotransferase criterion assessed during the first week. A recipient met the definition if any of the three criteria applied.
Bilirubin and INR reflect aspects of liver function. Aminotransferase release reflects cell injury. Reporting each component helps readers see what drove the composite result. The cohort linked the EAD classification with subsequent graft loss and patient mortality.
Lung: grade and assessment time
Diamond and colleagues followed 1,255 lung transplant recipients across 10 centres. The primary outcome was grade 3 PGD at 48 or 72 hours after transplantation. The cohort recorded 211 cases meeting that endpoint. The timing and grade matter because a report using a different time point can count a different set of recipients.
This was an observational study of donor, recipient and perioperative factors. Its outcome describes early dysfunction in the recipient. Studies of donor lungs on a perfusion circuit need their own measurements and a plan to follow recipient outcomes.
Connect measurements across the organ journey
A perfusion study can track oxygen delivery and uptake before implantation. A transplant study can then follow an organ-specific measure of function after implantation. Linking the two requires the same study to document when measurements were taken and which outcomes it planned to compare.
Within Precision Oxygen Therapeutics, BHOC Transplant proposes studying oxygen delivery by a Biological Hemoglobin Oxygen Carrier under defined perfusion conditions. The recipient outcome for such a study would depend on the organ and protocol. The cohorts above illustrate how to specify that outcome.